Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
BMS Bails on Checkpoint Inhibitor Teaming with CytomX, Stock Sinks
BioSpace
Tue, 03/12/24 - 06:54 pm
Tags:
Bristol Myers Squibb
,
CytomX
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
Tags:
CAR-T
,
Multiple Myeloma
,
FDA
,
Bristol Myers Squibb
,
2seventy bio
,
Abecma
,
JNJ
,
Legend Biotech
,
Carvykti
Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer
Fierce Pharma
Fri, 03/8/24 - 11:54 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
FDA
,
bladder cancer
Bristol Myers Squibb reports data from Phase III multiple sclerosis trial
Clinical Trials Arena
Fri, 03/1/24 - 11:39 am
Tags:
Bristol Myers Squibb
,
clinical trials
,
Zeposia
,
MS
,
multiple sclerosis
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
Tags:
radiopharmaceuticals
,
oncology
,
Novartis
,
Eli Lilly
,
Bristol Myers Squibb
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Reuters
Tue, 02/27/24 - 11:17 am
Tags:
Bristol Myers Squibb
,
R&D
,
India
Bristol Myers Squibb invests over $400m in sterile drug product facility
Biopharma Reporter
Thu, 02/22/24 - 11:38 am
Tags:
Bristol Myers Squibb
,
drug manufacturing
,
Europe
,
Dublin
,
Ireland
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Tags:
Novo Nordisk
,
Novartis
,
JNJ
,
Bristol Myers Squibb
,
legal
,
Inflation Reduction Act
,
drug pricing
BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues
Fierce Biotech
Tue, 02/13/24 - 11:31 am
Tags:
Bristol Myers Squibb
,
Roivant
,
VantAI
,
artificial intelligence
,
molecular glue
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
Tags:
earnings
,
COVID-19
,
GLP-1 agonist
,
JNJ
,
Bristol Myers Squibb
,
Pfizer
,
AstraZeneca
,
Sanofi
,
Eli Lilly
,
Novo Nordisk
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Tags:
Senate
,
drug pricing
,
Pharma CEOs
,
Bristol Myers Squibb
,
Chris Boerner
,
JNJ
,
Joaquin Duato
,
Merck
,
Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Tags:
Bernie Sanders
,
drug pricing
,
Pharma CEOs
,
Senate
,
Merck
,
Bristol Myers Squibb
,
JNJ
,
Rob Davis
,
Chris Boerner
,
Joaquin Duato
With Merck, J&J and BMS CEOs set to testify, Sanders releases scathing report on drug prices
Fierce Pharma
Tue, 02/6/24 - 11:33 pm
Tags:
Bernie Sanders
,
drug pricing
,
Merck
,
JNJ
,
Bristol Myers Squibb
,
Pharma CEOs
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
Tags:
oncology
,
cancer
,
Keytruda
,
Revlimid
,
Opdivo
,
Imbruvica
,
Darzalex
,
Merck
,
Bristol Myers Squibb
,
AbbVie
,
Janssen
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Tags:
Bristol Myers Squibb
,
Abecma
,
FRDA
,
CAR-T
,
JNJ
,
Carvykti
Bristol Myers CEO sees mid-decade transition, late decade growth
Reuters
Sun, 02/4/24 - 12:35 pm
Tags:
Bristol Myers Squibb
,
Pharma CEOs
,
Chris Boerner
BMS more likely to bet on bolt-ons after recent buying spree
Fierce Biotech
Fri, 02/2/24 - 11:59 am
Tags:
Bristol Myers Squibb
,
M&A
,
earnings
Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
BioPharma Dive
Tue, 01/30/24 - 11:10 am
Tags:
Cour Pharmaceuticals
,
funding
,
autoimmune disease
,
Roche
,
Pfizer
,
Bristol Myers Squibb
,
nanoparticles
BMS' subcutaneous Opdivo clears first phase 3 trial
Pharmaphorum
Mon, 01/29/24 - 11:05 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
clinical trials
,
kidney cancer
,
subcutaneous Opdivo
BMS won out against other pharmas in bid for RayzeBio, just days after competing for Karuna
Fierce Biotech
Thu, 01/25/24 - 09:02 pm
Tags:
Bristol Myers Squibb
,
M&A
,
Rayze Bio
,
radiopharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.